RCEL250117C22500
- 0.00
- 0.000.00%
Avita Medical Newsroom
Lake Street Maintains Avita Medical(RCEL.US) With Buy Rating, Maintains Target Price $20
Lake Street Gives a Buy Rating to Avita Medical (RCEL)
AVITA Medical Gets FDA Clearance for Wound Treatment; Shares Rise After Hours
Express News | AVITA Medical Inc - to Develop Clinical Data for Cohealyx in Early 2025
Express News | AVITA Medical Announces FDA 510(K) Clearance for Cohealyx, Expanding Its Addressable Market
Why Is AVITA Medical Inc. (RCEL) Among the Best Cosmetic Surgery and Aesthetics Stocks to Invest In Now?
AVITA Medical to Present at the Piper Sandler 36th Annual Healthcare Conference
Express News | AVITA Medical Announces Exclusive Distribution Agreement to Expand to Australia and New Zealand
Avita Medical's Total Revenue Climbs 44% in Q3; Net Loss Widens
Avita Medical Target Price Raised 28% to A$4.60/Share by Bell Potter>AVH.AU
AVITA Medical, Inc. (RCEL) Q3 2024 Earnings Call Transcript
Lake Street Maintains Avita Medical(RCEL.US) With Buy Rating, Cuts Target Price to $20
AVITA Medical to Host Investor Webinar Briefing
Express News | Piper Sandler Reiterates Neutral on AVITA Medical, Raises Price Target to $12
AVITA Medical Analyst Ratings
Avita Medical: Strong Buy Rating Backed by Record Sales and Promising Growth Prospects
Express News | Avita Medical Shares Are Trading Higher After the Company Issued Q4 Revenue Guidance Above Estimates
Express News | Corrected-AVITA Medical Inc - Q3 Commercial Revenue of $19.5 Mln (Corrects Currency to USD)
10-Q: Q3 2024 Earnings Report
Express News | AVITA Medical Sees Q4 2024 Revenue $22.3M-$24.3M Vs $19.425M Est